在这个特殊的研究中,氨基或HAAH c端三分之二的被发现表情λ-phage(200 – 300)副本。研究发现，这种抗肿瘤疫苗能够控制和确保小鼠的抗haah多克隆抗体。在HAAH基因的例子中，它被发现在小鼠和人类中是不同的。研究发现，雌性BALB / c小鼠接种10E09或10E10噬菌体颗粒，显示HAAH的n端或c端。有一个对照组，也使用了它没有任何HAAH序列。免疫是在特定的日子进行的。
The purpose of this research was to understand the impact of the nanoparticle vaccine in the tumor marker Human aspartyl (asparaginyl) β-hydroxylase (HAAH) in the case of breast cancer. It was found that HAAH is responsible for the abnormal cell proliferation, its motility and metastasis. This was found from previous research. Based on the paradigm that HAAH is the main causative factor for the progression of the cancer. It was found that when this HAAH gets neutralized, there is a neutralization or inhibition of the cancer progression. Anti Haah antibody is used to inhibit the cancer progressions.
In this particular research, the N-terminal or C-terminal thirds of HAAH was found to be expression on the λ-phage (200-300 copies). It was found that this anticancer vaccine was able to control and ensure that the anti-HAAH polyclonal antibodies in mice. In the case of HAAH gene, it was found to be different in mice and humans. It was found that the female BALB/c mice were immunized with 10E09 or 10E10 phage particles display the N-terminalor C-terminal of the HAAH. There was a control group that was also used and it did not have any HAAH sequence. The immunization was performed on specific days.